Skip to main content

Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium

Description

This document in this compendium was contributed by the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium which is part of the Rare Diseases Clinical Research Network (RDCRN; https://www.rarediseasesnetwork.org/). RDCRN is focused on therapeutic developments for amyotrophic lateral sclerosis, frontotemporal dementia, primary lateral sclerosis, hereditary spastic paraplegia, and progressive muscular atrophy. This SOP is available from https://create.rarediseasesnetwork.org/biorepository.

Sources

  • CReATe

Standard Operating Procedures (1)

TitleVersionSource
BIOSPECIMEN COLLECTION SOP
CReATe